Modified peptide / Material & research guide
Cagrilintide
Cagrilintide is an amylin analogue. A standalone cagrilintide material is distinct from a mixture containing semaglutide.
Catalog specification — select for your inquirySelected: 5 mg × 10 vials
Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.
Material profile
About the material
Cagrilintide is an amylin analogue. A standalone cagrilintide material is distinct from a mixture containing semaglutide.
For Cagrilintide, the useful starting point is the material identity—not the broad research category. Compare the complete name and supplied form with the reference used by your laboratory.
State explicitly whether the request is for the standalone material. Confirm the modification, salt, nominal fill and applicable identity test.
Scientific context
Research context
Amylin-related research and combination studies answer different questions. Co-administration of separate study products does not validate a premixed catalog vial.
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.
Lancet (London, England) · 2023 · PMID 37364590
This is combination-research context. It does not establish the properties of a standalone supply or validate a premixed formulation.
Read the primary publication ↗Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Lancet (London, England) · 2021 · PMID 33894838
This is combination-research context. It does not establish the properties of a standalone supply or validate a premixed formulation.
Read the primary publication ↗For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.
Catalog & quotation
Specifications
| Catalog material | Cagrilintide |
|---|---|
| Material class | Modified peptide |
| Listed options | 5 mg × 10 vials 10 mg × 10 vials |
| Identity / supplied form | State explicitly whether the request is for the standalone material. Confirm the modification, salt, nominal fill and applicable identity test. |
| Identity, purity and content | Request the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements. |
| Storage / stability | Follow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed. |
Evidence for the offered material
Documents
Confirm document availability for the actual material and lot. A catalog purity target or packaging label is not a released batch result.
State explicitly whether the request is for the standalone material. Confirm the modification, salt, nominal fill and applicable identity test.
Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.
Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.
Before you inquire
Questions
Is this standalone cagrilintide or a combination?
State explicitly whether the request is for the standalone material. Confirm the modification, salt, nominal fill and applicable identity test.
What should my Cagrilintide inquiry include?
Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.
Does the catalog image confirm the selected specification?
No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.
Does a paper or an existing report validate every future batch?
No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.
Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.
Build your Cagrilintide inquiry.
Include the material, amount and evidence your laboratory needs to review.